IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,167,760 | +1.2% | 246,203 | -8.5% | 0.02% | +6.7% |
| Q2 2023 | $11,036,306 | +14.4% | 268,981 | -0.3% | 0.02% | +7.1% |
| Q1 2023 | $9,643,777 | -5.3% | 269,831 | +0.0% | 0.01% | -6.7% |
| Q4 2022 | $10,188,239 | -23.2% | 269,744 | -10.1% | 0.02% | -31.8% |
| Q3 2022 | $13,269,000 | +17.0% | 300,013 | -2.1% | 0.02% | +22.2% |
| Q2 2022 | $11,341,000 | -10.1% | 306,320 | -10.1% | 0.02% | +5.9% |
| Q1 2022 | $12,615,000 | +15.8% | 340,566 | -4.9% | 0.02% | +21.4% |
| Q4 2021 | $10,892,000 | -13.7% | 357,948 | -4.9% | 0.01% | -26.3% |
| Q3 2021 | $12,619,000 | -16.2% | 376,219 | -0.4% | 0.02% | -17.4% |
| Q2 2021 | $15,066,000 | -11.9% | 377,685 | -0.7% | 0.02% | -17.9% |
| Q1 2021 | $17,103,000 | -17.0% | 380,398 | +4.4% | 0.03% | -24.3% |
| Q4 2020 | $20,595,000 | +20.2% | 364,242 | +0.8% | 0.04% | +5.7% |
| Q3 2020 | $17,138,000 | -22.4% | 361,178 | -3.5% | 0.04% | -31.4% |
| Q2 2020 | $22,073,000 | +19.4% | 374,377 | -4.2% | 0.05% | 0.0% |
| Q1 2020 | $18,488,000 | -21.5% | 390,696 | +0.2% | 0.05% | +4.1% |
| Q4 2019 | $23,539,000 | -3.4% | 389,779 | -4.2% | 0.05% | -21.0% |
| Q3 2019 | $24,362,000 | -10.6% | 406,739 | -4.1% | 0.06% | -11.4% |
| Q2 2019 | $27,262,000 | -28.6% | 424,161 | -9.9% | 0.07% | -35.2% |
| Q1 2019 | $38,196,000 | +20.7% | 470,899 | -19.6% | 0.11% | +5.9% |
| Q4 2018 | $31,654,000 | +1.2% | 585,900 | -3.3% | 0.10% | +13.3% |
| Q3 2018 | $31,264,000 | +19.9% | 606,027 | -3.0% | 0.09% | +12.5% |
| Q2 2018 | $26,065,000 | -2.8% | 624,507 | +2.6% | 0.08% | -5.9% |
| Q1 2018 | $26,818,000 | -12.6% | 608,763 | -0.1% | 0.08% | -12.4% |
| Q4 2017 | $30,687,000 | -1.3% | 609,559 | -0.6% | 0.10% | -10.2% |
| Q3 2017 | $31,090,000 | +1.9% | 612,952 | +2.2% | 0.11% | -4.4% |
| Q2 2017 | $30,502,000 | +27.0% | 599,532 | +0.3% | 0.11% | +21.5% |
| Q1 2017 | $24,008,000 | -15.6% | 597,848 | +0.6% | 0.09% | -23.1% |
| Q4 2016 | $28,435,000 | +38.3% | 594,193 | +6.0% | 0.12% | +31.5% |
| Q3 2016 | $20,565,000 | +48.6% | 560,696 | -5.7% | 0.09% | +43.8% |
| Q2 2016 | $13,843,000 | -63.8% | 594,308 | -3.8% | 0.06% | -67.8% |
| Q4 2015 | $38,277,000 | – | 618,066 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |